Seasonal malaria chemoprevention (SMC) is a safe and effective intervention recommended by the World Health Organization for the prevention of malaria in children 3–59 months in the Sahel region. Clinical trials have shown SMC prevents around 75 percent of clinical malaria episodes. The impact under routine programmatic conditions has been assessed during research studies but there is a need to identify sustainable methods to monitor impact using routinely collected data. Data from demographic health surveys/malaria indicator surveys are of high quality, yet have been overlooked in the context of measuring SMC impact.
This poster was presented at the 70th annual meeting of the American Society of Tropical Medicine and Hygiene.Community delivery | Health system strengthening | Malaria | SMC | SDGs
« Back to Publications